Tumor-induced Osteomalacia Disease Monitoring Program

Clinical trial NCT04783428 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04783428
Sponsor: Ultragenyx Pharmaceutical Inc
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Tumor-induced Osteomalacia (TIO)

Start date: 2022-01-31
Primary completion: 2032-02-28
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.